|
1
|
Rishu AH, Marinoff N, Julien L, Dumitrascu M, Marten N, Eggertson S, Willems S, Ruddell S, Lane D, Light B, Stelfox HT, Jouvet P, Hall R, Reynolds S, Daneman N, Fowler RA. Time required to initiate outbreak and pandemic observational research. J Crit Care 2017; 40:7-10. [PMID: 28288355 PMCID: PMC7126421 DOI: 10.1016/j.jcrc.2017.02.009] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2016] [Revised: 12/15/2016] [Accepted: 02/01/2017] [Indexed: 01/09/2023]
Abstract
PURPOSE Observational research focused upon emerging infectious diseases such as Ebola virus, Middle East respiratory syndrome, and Zika virus has been challenging to quickly initiate. We aimed to determine the duration of start-up procedures and barriers encountered for an observational study focused upon such infectious outbreaks. MATERIALS AND METHODS At 1 pediatric and 5 adult intensive care units, we measured durations from protocol receipt to a variety of outbreak research milestones, including research ethics board (REB) approval, data sharing agreement (DSA) execution, and patient study screening initiation. RESULTS The median (interquartile range) time from site receipt of the protocol to REB submission was 73 (30-126) days; to REB approval, 158 (42-188) days; to DSA completion, 276 (186-312) days; and to study screening initiation, 293 (269-391) days. The median time from REB submission to REB approval was 43 (13-85) days. The median time for all start-up procedures was 335 (188-335) days. CONCLUSIONS There is a lengthy start-up period required for outbreak-focused research. Completing DSAs was the most time-consuming step. A reactive approach to newly emerging threats such as Ebola virus, Middle East respiratory syndrome, and Zika virus will likely not allow sufficient time to initiate research before most outbreaks are advanced.
Collapse
Affiliation(s)
- Asgar H Rishu
- Department of Critical Care Medicine, Sunnybrook Health Sciences Center, Toronto, Ontario, M4N 3M5, Canada
| | - Nicole Marinoff
- Department of Critical Care Medicine, Sunnybrook Health Sciences Center, Toronto, Ontario, M4N 3M5, Canada
| | - Lisa Julien
- Division of Critical Care Medicine, Dalhousie University and the Capital District Health Authority, Halifax, Nova Scotia, B3H 1V7, Canada
| | - Mariana Dumitrascu
- Département de Pédiatrics et Soins Intensifs, Hôpital Ste-Justine, l'Université de Montréal, Montréal, Québec, H3T 1C5, Canada
| | - Nicole Marten
- Section of Critical Care Medicine, St Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, R2H 2A6, Canada
| | - Shauna Eggertson
- Section of Critical Care Medicine, St Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, R2H 2A6, Canada
| | - Su Willems
- Department of Critical Care Medicine, Royal Columbian Hospital, University of British Columbia, Vancouver, British Columbia, V3L 3W7, Canada
| | - Stacy Ruddell
- Department of Critical Care Medicine, Foothills Hospital, University of Calgary, Alberta, Canada T2N 2T9
| | - Dan Lane
- Department of Critical Care Medicine, Foothills Hospital, University of Calgary, Alberta, Canada T2N 2T9
| | - Bruce Light
- Section of Critical Care Medicine, St Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, R2H 2A6, Canada
| | - Henry T Stelfox
- Department of Critical Care Medicine, Foothills Hospital, University of Calgary, Alberta, Canada T2N 2T9
| | - Philippe Jouvet
- Département de Pédiatrics et Soins Intensifs, Hôpital Ste-Justine, l'Université de Montréal, Montréal, Québec, H3T 1C5, Canada
| | - Richard Hall
- Division of Critical Care Medicine, Dalhousie University and the Capital District Health Authority, Halifax, Nova Scotia, B3H 1V7, Canada
| | - Steven Reynolds
- Department of Critical Care Medicine, Royal Columbian Hospital, University of British Columbia, Vancouver, British Columbia, V3L 3W7, Canada
| | - Nick Daneman
- Division of Infectious Diseases, Department of Medicine and Clinical Epidemiology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada M4N 3M5
| | - Robert A Fowler
- Departments of Medicine and Critical Care Medicine, Sunnybrook Health Sciences Center, Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada M4N 3M5.
| |
Collapse
|